Guidelines for the Evaluation and Management of Status Epilepticus
... following search terms: status epilepticus, refractory seizures, and nonconvulsive status epilepticus plus individual seizure treatments, including standard medications and other anticonvulsive therapies (e.g., cooling and ketogenic diet). The search was limited to articles describing human subjects ...
... following search terms: status epilepticus, refractory seizures, and nonconvulsive status epilepticus plus individual seizure treatments, including standard medications and other anticonvulsive therapies (e.g., cooling and ketogenic diet). The search was limited to articles describing human subjects ...
Quebec - Canadian Skin Patient Alliance
... This report represents just a snapshot of some of the issues that affect many patients and has taken considerable time to put together. While we’ve tried to cover many of the issues, we already know we’ve missed some. Whether it’s funding coverage for wigs for alopecia patients, or access to treatme ...
... This report represents just a snapshot of some of the issues that affect many patients and has taken considerable time to put together. While we’ve tried to cover many of the issues, we already know we’ve missed some. Whether it’s funding coverage for wigs for alopecia patients, or access to treatme ...
Management of Acute Pancreatitis
... pancreatic duct stents or endoscopic sphincterotomy (biliary or pancreatic) in patients with TIRAP.[40,88] There is only 1 prospective, randomized trial to have evaluated the use of pancreatic duct stents for this indication.[89] Patients randomized to stent placement suffered fewer episodes of panc ...
... pancreatic duct stents or endoscopic sphincterotomy (biliary or pancreatic) in patients with TIRAP.[40,88] There is only 1 prospective, randomized trial to have evaluated the use of pancreatic duct stents for this indication.[89] Patients randomized to stent placement suffered fewer episodes of panc ...
Influence of Minimum Inhibitory Concentration in Clinical Outcomes
... a specific E. faecium genetic clade worldwide that harbors multiple antibiotic-resistance determinants [7]. Additionally, several studies have now shown that the presence of vancomycin resistance in enterococci is strongly associated with worse clinical outcomes, including significantly higher mortali ...
... a specific E. faecium genetic clade worldwide that harbors multiple antibiotic-resistance determinants [7]. Additionally, several studies have now shown that the presence of vancomycin resistance in enterococci is strongly associated with worse clinical outcomes, including significantly higher mortali ...
A Tuberculosis Guide for Specialist Physicians
... Speculations on the origin of Mycobacterium tuberculosis Tuberculosis (TB) is one of the oldest diseases known to affect humans. The causal microorganism is one of the best examples of how the selection process allows the survival of a species that has been able to adapt to change and adverse condit ...
... Speculations on the origin of Mycobacterium tuberculosis Tuberculosis (TB) is one of the oldest diseases known to affect humans. The causal microorganism is one of the best examples of how the selection process allows the survival of a species that has been able to adapt to change and adverse condit ...
NAEPP 2007 Asthma Guideline UPDATE
... Summarizes extensively-validated scientific evidence that the guidelines, when followed, lead to a significant reduction in the frequency and severity of asthma symptoms and improve quality of life. ...
... Summarizes extensively-validated scientific evidence that the guidelines, when followed, lead to a significant reduction in the frequency and severity of asthma symptoms and improve quality of life. ...
Prevention and treatment of infections in patients with haematological malignancies 1
... Signs and symptoms of infection can be minimal in the patient with neutropenia. Fever may be the first and sometimes only manifestation of serious infection, and even the febrile response may be blunted if steroids or other immunosuppressive agents are used.11,12 In these patients rapidly progressiv ...
... Signs and symptoms of infection can be minimal in the patient with neutropenia. Fever may be the first and sometimes only manifestation of serious infection, and even the febrile response may be blunted if steroids or other immunosuppressive agents are used.11,12 In these patients rapidly progressiv ...
Relapse & Recovery: Behavioral Strategies for Change Published By Caron Treatment Centers
... treatment for hypertension, asthma, depression or most other chronic conditions do NOT do well in their first treatment attempt. Most do not immediately gain control of their lifestyle (eating habits, exercise, etc.) and most do not respond optimally to their first medication. Poor response (we cal ...
... treatment for hypertension, asthma, depression or most other chronic conditions do NOT do well in their first treatment attempt. Most do not immediately gain control of their lifestyle (eating habits, exercise, etc.) and most do not respond optimally to their first medication. Poor response (we cal ...
PRESCRIBING INFORMATION
... Antacids containing aluminum, calcium or magnesium impair absorption and should not be given to patients taking VIBRAMYCIN/VIBRA-TABS. The concurrent use of VIBRAMYCIN/VIBRA-TABS (doxycycline hyclate) with alcohol, barbiturates, phenytoin and carbamazepine (hepatic enzyme inducers) has been reported ...
... Antacids containing aluminum, calcium or magnesium impair absorption and should not be given to patients taking VIBRAMYCIN/VIBRA-TABS. The concurrent use of VIBRAMYCIN/VIBRA-TABS (doxycycline hyclate) with alcohol, barbiturates, phenytoin and carbamazepine (hepatic enzyme inducers) has been reported ...
Risperidon STADA film-coated tablet ENG SmPC
... Risperidon STADA is indicated for the treatment of schizophrenia. Risperidon STADA is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorders. Risperidon STADA is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients wi ...
... Risperidon STADA is indicated for the treatment of schizophrenia. Risperidon STADA is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorders. Risperidon STADA is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients wi ...
Document
... c. Always have a first line medication to take at onset and a second line to take 2 hours later for persistent headache d. First line therapy should not contain a sedating medication and child can return back to school work e. Second line therapy may contain a sedating medication and child should re ...
... c. Always have a first line medication to take at onset and a second line to take 2 hours later for persistent headache d. First line therapy should not contain a sedating medication and child can return back to school work e. Second line therapy may contain a sedating medication and child should re ...
Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis
... of using green or yellow sputum colour as a diagnostic test for the presence of a PPM, the following diagnostic test statistics, including 95% confidence intervals were calculated for each of the six clinical trials: sensitivity, specificity, positive predictive value, negative predictive value, pos ...
... of using green or yellow sputum colour as a diagnostic test for the presence of a PPM, the following diagnostic test statistics, including 95% confidence intervals were calculated for each of the six clinical trials: sensitivity, specificity, positive predictive value, negative predictive value, pos ...
Psychogenic Non-epileptic Seizures
... not uncommon in those with PNES and the association is stronger in PNES than in epilepsy. • Fibromyalgia and chronic pain • 10-30% of patients with PNES also have past or present epilepsy as well ...
... not uncommon in those with PNES and the association is stronger in PNES than in epilepsy. • Fibromyalgia and chronic pain • 10-30% of patients with PNES also have past or present epilepsy as well ...
Difficult to Manage Asthma 2016
... Cholinesterase inhibitors: tacrine, rivastigmine MDI propellants ...
... Cholinesterase inhibitors: tacrine, rivastigmine MDI propellants ...
Dr. Julius Hellenthal, MD The sensational medical revolution on the
... In his book, our fellow physician Julius Hellenthal approaches in no uncertain terms a subject which has surely been a source of unease for some time now for many physicians. At a time when the administration of antibiotics causes wariness among doctors and patients alike, he demonstrates through hi ...
... In his book, our fellow physician Julius Hellenthal approaches in no uncertain terms a subject which has surely been a source of unease for some time now for many physicians. At a time when the administration of antibiotics causes wariness among doctors and patients alike, he demonstrates through hi ...
Guidelines for the management of atrial fibrillation
... Disclaimer. The ESC Guidelines represent the views of the ESC and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, ...
... Disclaimer. The ESC Guidelines represent the views of the ESC and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, ...
Allergic and Pseudoallergic Drug Reactions
... are advised not to receive cephalosporins if they can be avoided. Patients who have negative penicillin skin test results or experienced only mild cutaneous reactions, such as maculopapular rashes, have a low risk of serious reactions to cephalosporins. Similarities in the R1 side chain of the agent ...
... are advised not to receive cephalosporins if they can be avoided. Patients who have negative penicillin skin test results or experienced only mild cutaneous reactions, such as maculopapular rashes, have a low risk of serious reactions to cephalosporins. Similarities in the R1 side chain of the agent ...
Management of Patients with Opioid Dependence
... A 2009 Cochrane systematic review of clinical trials found consistently superior outcomes for maintenance treatment approaches compared to short-term (i.e., <30 days) opioid withdrawal protocols. Maintenance was associated with better treatment retention and lower rates of illicit drug use compared ...
... A 2009 Cochrane systematic review of clinical trials found consistently superior outcomes for maintenance treatment approaches compared to short-term (i.e., <30 days) opioid withdrawal protocols. Maintenance was associated with better treatment retention and lower rates of illicit drug use compared ...
Product Monograph
... patients with renal impairment since the appropriate dosage in this patient population has not yet been established. Bone Fracture Several published observational studies suggest that PPI therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist, or spine. ...
... patients with renal impairment since the appropriate dosage in this patient population has not yet been established. Bone Fracture Several published observational studies suggest that PPI therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist, or spine. ...
Rispalan film-coated tablet ENG SmPC
... Rispalan should be administered on a once daily schedule, starting with 2 mg risperidone. Dosage adjustments, if indicated, should occur at intervals of not less than 24 hours and in dosage increments of 1 mg per day. Risperidone can be administered in flexible doses over a range of 1 to 6 mg per da ...
... Rispalan should be administered on a once daily schedule, starting with 2 mg risperidone. Dosage adjustments, if indicated, should occur at intervals of not less than 24 hours and in dosage increments of 1 mg per day. Risperidone can be administered in flexible doses over a range of 1 to 6 mg per da ...
Summer 2002, Volume 10, Number 2 (PDF, 109K file)
... visible breast density. The explanation for this association has been elusive, with no evidence to date for either a direct causal pathway or the existence of factors that independently affect both breast density and breast cancer risk (i.e., the increased cancer risk may be due to one or more facto ...
... visible breast density. The explanation for this association has been elusive, with no evidence to date for either a direct causal pathway or the existence of factors that independently affect both breast density and breast cancer risk (i.e., the increased cancer risk may be due to one or more facto ...
(OAM) and the National Heart, Lung and Blood Institute funded
... practice and has been listed as a nursing intervention" - background significance: "complementary therapies increased from 34% to more than 40% between 1990 and 1997 with a specific increase in the use of touch or energy therapies...more than 30 000 nurses are estimated to prectice touch therapies." ...
... practice and has been listed as a nursing intervention" - background significance: "complementary therapies increased from 34% to more than 40% between 1990 and 1997 with a specific increase in the use of touch or energy therapies...more than 30 000 nurses are estimated to prectice touch therapies." ...
Clinical management of progressive myopia
... OrthoK requires a trial fitting set and a topographer is also essential to the fitting and follow-up process. Once the cornea has undergone reshaping, eyes are left with minimal refractive error, making it nearly impossible to detect mild myopic progression. Thus, in order to monitor progression, an ...
... OrthoK requires a trial fitting set and a topographer is also essential to the fitting and follow-up process. Once the cornea has undergone reshaping, eyes are left with minimal refractive error, making it nearly impossible to detect mild myopic progression. Thus, in order to monitor progression, an ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.